Cash · 2011–2025
Travere Therapeutics cash
$93.0M+58.9% · FY2025
Travere Therapeutics (TVTX) reported $93.0M in cash for fiscal 2025, +58.9% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $93.0M | +58.9% | Open → |
| FY20242024-12-31 | $58.5M | +0.6% | Open → |
| FY20232023-12-31 | $58.2M | −5.7% | Open → |
| FY20222022-12-31 | $61.7M | −62.8% | Open → |
| FY20212021-12-31 | $166M | +95.5% | Open → |
| FY20202020-12-31 | $84.8M | +35.8% | Open → |
| FY20192019-12-31 | $62.4M | −39.3% | Open → |
| FY20182018-12-31 | $103M | +3.5% | Open → |
| FY20172017-12-31 | $99.4M | +142.4% | Open → |
| FY20162016-12-31 | $41.0M | +8.5% | Open → |
| FY20152015-12-31 | $37.8M | +107.7% | Open → |
| FY20142014-12-31 | $18.2M | +203.6% | Open → |
| FY20132013-12-31 | $6.0M | +54,418.2% | Open → |
| FY20122012-12-31 | $11,000 | +9.4% | Open → |
| FY20112011-12-31 | $10,053 | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +92.0%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Travere Therapeutics cash |url=https://companiesranked.com/en/company/travere-therapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Travere Therapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/travere-therapeutics/cash-on-handBibTeX
@misc{companiesranked-en-company-travere-therapeutics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Travere Therapeutics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/travere-therapeutics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001438533-26-000063 · August 4, 2026
{{cite web |title=Travere Therapeutics cash — 10-Q (0001438533-26-000063) |url=https://www.sec.gov/Archives/edgar/data/1438533/000143853326000063/tvtx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.